相关实验视频

Updated: May 2, 2026

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

Published on: December 10, 2013

传染性支气管炎病毒在体外感染期间激活阿里尔碳化合物受体

Mingjing Zhang¹, Zhichao Cai¹, Hongliu An¹

¹College of Agriculture, Yangtze University, Jingzhou 434025, China.

Veterinary sciences

|October 28, 2025

概括

鸟类传染性支气管炎病毒 (IBV) 劫持了酸受体 (AhR),以促进其复制并逃避免疫力. 阻止AhR显示为对抗冠状病毒的广泛抗病毒策略的承诺.

科学领域:

病毒学病毒学
免疫学免疫学免疫学
分子生物学分子生物学

背景情况:

冠状病毒,包括禽传染性支气管炎病毒 (IBV),利用宿主细胞通路进行免疫逃避.
基碳化合物受体 (AhR) 是已知的抗病毒反应调节器,由SARS-CoV-2利用,但其在禽类冠状病毒中的作用尚不清楚.

研究的目的:

调查酸受体 (AhR) 在禽传染性支气管炎病毒 (IBV) 病原发生中的作用.
确定AhR对抗性是否可以作为对IBV的治疗策略.

主要方法:

在IBV感染研究中使用H1299和Vero细胞.
采用药理调制 (AhR抗剂CH223191,激动剂kynurenine) 和shRNA介导的AhR沉默.
使用斑块检测,qRT-PCR和西方斑点的量化病毒复制.

主要成果:

IBV感染激活了AhR,导致CYP1A1表达和促炎细胞因子的增加.
抑制AHR与CH223191的剂量依赖性降低病毒标位,RNA和N蛋白表达.
抗AhR还降低了N蛋白的表达,证实了它的前病毒功能.
一个IBV非编码RNA被确定为一个AhR调节器.

结论:

艾赫R作为一种保存宿主因子,被IBV选择用于复制和免疫逃避.
AhR对抗性为IBV感染提供了潜在的治疗途径.
这项研究弥合了鸟类和哺乳动物冠状病毒的洞察力,为广泛的抗病毒开发提供了信息.

关键词:

阿里碳水化合物受体是什么?主体的治疗目标是宿主.感染性支气管炎病毒感染性支气管炎病毒

更多相关视频

Contact-Free Co-Culture Model for the Study of Innate Immune Cell Activation During Respiratory Virus Infection

Contact-Free Co-Culture Model for the Study of Innate Immune Cell Activation During Respiratory Virus Infection

Published on: February 28, 2021

Isolating Bronchial Epithelial Cells from Resected Lung Tissue for Biobanking and Establishing Well-Differentiated Air-Liquid Interface Cultures

Isolating Bronchial Epithelial Cells from Resected Lung Tissue for Biobanking and Establishing Well-Differentiated Air-Liquid Interface Cultures

Published on: May 26, 2023

相关概念视频

GPCRs Regulate Adenylyl Cylase Activity

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...

Asthma I: Introduction

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...